[CRVS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
29-Oct-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 7.68%
YoY- 10.98%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,752 -11,580 27,347 -9,796 -10,611 -12,935 -11,047 4.21%
Tax -1 -3 -143 0 0 0 -185 -96.92%
NP -11,752 -11,580 27,347 -9,796 -10,611 -12,935 -11,047 4.21%
Tax Rate - - 0.52% - - - - -
Total Cost 11,752 11,580 -27,347 9,796 10,611 12,935 11,047 4.21%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.28 -0.34 0.92 -0.33 -0.36 -0.44 -0.38 -18.43%
EPS Diluted -0.28 -0.34 0.92 -0.33 -0.36 -0.44 -0.38 -18.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.